Spider venom holds promise of chronic-pain relief

Scientists in Australia think venomous species of spiders could help develop new generation of pain-relieving drugs.

    Hundreds of millions of people around the world suffer from what doctors call "chronic pain".

    They cannot take anasthetics like morphine because, in the long term, their bodies would develop a tolerance to them. In high-doses, pain-relief drugs can have debilitating side-effects.

    But as Al Jazeera's Andrew Thomas reports from Brisbane in Australia, scientists at the University of Queensland think that spider venom could contain the secrets of effective pain relief.

    "I cannot think of anything that’s as chemically complex in nature as spider venom," Institute of Molecular Bioscience researcher Glenn King, tells Al Jazeera.

    "They are the most complex of any of the venomous animals."

    King and others are studying the compounds found in the venom of tarantulas.

    Within the hundreds of chemicals that make up a tarantula's venom are some that affect the nerve system.

    Some block the channels that deliver pain signals to the brain while others lead to paralysis.

    They believe that working out exactly which molecules do what could revolutionise treatment for sufferers of chronic pain.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    'It takes a village to kill a child': Uganda's hidden children

    'It takes a village to kill a child': Uganda's hidden children

    Faced with stigma and abuse, many children with disabilities are hidden indoors, with few options for specialised care.

    Medieval Arabic cookbooks: Reviving the taste of history

    Medieval Arabic cookbooks: Reviving the taste of history

    A growing number of cookbooks have been translated into English, helping bring old foods to new palates.

    India-China border row explained in seven maps

    India-China border row explained in seven maps

    Seven maps to help you understand the situation on the ground and what's at stake for nearly three billion people.